Details for New Drug Application (NDA): 202544
✉ Email this page to a colleague
NDA 202544 describes TELMISARTAN AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Alembic, Aurobindo Pharma, Glenmark Pharms Ltd, Lupin Ltd, Macleods Pharms Ltd, Natco, Prinston Inc, Torrent, and Zydus Pharms, and is included in nine NDAs. It is available from nine suppliers. Additional details are available on the TELMISARTAN AND HYDROCHLOROTHIAZIDE profile page.
The generic ingredient in TELMISARTAN AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; telmisartan. There are thirty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; telmisartan profile page.
The generic ingredient in TELMISARTAN AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; telmisartan. There are thirty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; telmisartan profile page.
Summary for 202544
| Tradename: | TELMISARTAN AND HYDROCHLOROTHIAZIDE |
| Applicant: | Glenmark Pharms Ltd |
| Ingredient: | hydrochlorothiazide; telmisartan |
| Patents: | 0 |
Pharmacology for NDA: 202544
| Mechanism of Action | Angiotensin 2 Receptor Antagonists |
| Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 202544
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TELMISARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; telmisartan | TABLET;ORAL | 202544 | ANDA | AvKARE | 42291-462 | 42291-462-30 | 3 BLISTER PACK in 1 BOX (42291-462-30) / 10 TABLET in 1 BLISTER PACK (42291-462-11) |
| TELMISARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; telmisartan | TABLET;ORAL | 202544 | ANDA | AvKARE | 42291-463 | 42291-463-30 | 3 BLISTER PACK in 1 BOX (42291-463-30) / 10 TABLET in 1 BLISTER PACK (42291-463-11) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;40MG | ||||
| Approval Date: | Mar 4, 2019 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;80MG | ||||
| Approval Date: | Mar 4, 2019 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;80MG | ||||
| Approval Date: | Mar 4, 2019 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
